Read More Pharma Industry News Novartis secures EC approval for Gilenya in pediatric multiple sclerosis treatment Novartis has announced that the European Commission has expanded the approval of its multiple sclerosis drug, Gilenya (fingolimod),… bypharmanewsdailyDecember 2, 2018
